S
GBT

SignatureFD’s Global Blood Therapeutics, Inc. GBT Stock Holding History

SignatureFD’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18
Closed -$1K – 3472
2022
Q3 		$1K Buy
+18
New +$993 ﹤0.01% 3085
2021
Q1 		– Sell
-39
Closed -$2K – 2866
2020
Q4 		$2K Sell
39
-1
-3% -$49 ﹤0.01% 2350
2020
Q3 		$2K Hold
40
– – ﹤0.01% 2325
2020
Q2 		$3K Hold
40
– – ﹤0.01% 2053
2020
Q1 		$2K Buy
40
+39
+3,900% +$2.61K ﹤0.01% 2033
2019
Q4 		$0 Buy
+1
New +$59 ﹤0.01% 2320
2019
Q3 		– Sell
-1
Closed – – 2245
2019
Q2 		$0 Buy
+1
New +$57 ﹤0.01% 2202
2018
Q4 		– Sell
-2
Closed – – 2112
2018
Q3 		$0 Hold
2
– – ﹤0.01% 2033
2018
Q2 		$0 Hold
2
– – ﹤0.01% 1999
2018
Q1 		$0 Buy
+2
New +$112 ﹤0.01% 1782

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SignatureFD's GBT Position: Q4 2022 in Review

SignatureFD sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 18 shares — an estimated $1K sold.

SignatureFD first reported a position in GBT in Q1 2018 and held it in 10 quarters. The position peaked at $3K in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • SignatureFD reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • SignatureFD sold 18 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1K.
  • SignatureFD first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 10 quarters.
  • SignatureFD's Global Blood Therapeutics, Inc. position peaked at $3K in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on SignatureFD's 13F filing for Q4 2022, filed 30 Jan 2023.